ADAP - Adaptimmune Therapeutics plc (ADAP) CEO Adrian Rawcliffe on Q3 2021 Results - Earnings Call Transcript

Adaptimmune Therapeutics plc (ADAP) Q3 2021 Earnings Conference Call November 4, 2021 08:00 AM ET Company Participants Juli Miller - IR Adrian Rawcliffe - CEO Elliot Norry - Senior VP and Chief Medical Officer John Lunger - Chief Patient Supply Officer Helen Tayton-Martin - Co-Founder and Chief Business Officer Conference Call Participants Marc Frahm - Cowen & Company Michael Schmidt - Guggenheim Nick Abbott - Wells Fargo Mara Goldstein - Mizuho Presentation Operator Good day, and thank you for standing by. Welcome to the Q3 2021 Adaptimmune Earnings Conference Call. [Operator Instructions] After the speaker presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions] I would now like to hand the conference over to your speaker today, Juli Miller. Please go ahead. Juli Miller Good morning, and welcome to Adaptimmune's conference call to discuss our third quarter 2021 financial

For further details see:

Adaptimmune Therapeutics plc (ADAP) CEO Adrian Rawcliffe on Q3 2021 Results - Earnings Call Transcript